On Thursday, Following Stocks were among the “Top Gainers” In U.S. Stock Exchange: Plug Power Inc (NASDAQ:PLUG), Vipshop Holdings Ltd – ADR (NYSE:VIPS), Cerus Corporation (NASDAQ:CERS), Castlight Health Inc (NYSE:CSLT)
Plug Power Inc (NASDAQ:PLUG)’s shares picked up 4.63%, and closed at $2.71. The stock volatility for the week is 6.28%, while for the month remained 5.16%. The company holds consensus target price of $5.33.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.88 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 11.80% and Annual EPS growth for the past 5 years is considered as 43.00%.
The mean recommendation of analysts for this stock is 2.00. (where 1=Buy, 5=Sale).
Plug Power Inc., an alternative energy technology provider, is engaged in the design, development, manufacture, and commercialization of fuel cell systems for the industrial off-road markets worldwide. It is focused on proton exchange membrane (PEM) fuel cell and fuel processing technologies and fuel cell/battery hybrid technologies. The company’s product line comprises GenDrive, a hydrogen fueled PEM fuel cell system providing power to material handling vehicles; GenKey, its turn-key solution offering simplicity to customers transitioning their material handling vehicles to fuel cell power; GenFuel, its hydrogen fueling delivery system; and GenCare, its ongoing maintenance program for both the GenDrive fuel cells and GenFuel products. The company sells its products to businesses, government agencies, and commercial consumers through direct product sales force, original equipment manufacturers, and their dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.
Vipshop Holdings Ltd – ADR (NYSE:VIPS) raised 4.58%, and closed at $27.38, hitting new 52-week high of $27.52. The stock has price to sale ratio of 4.16, however, price to book ratio is 342.25. With recent incline, the year-to-date (YTD) performance reflected a 40.12% gain below last year. During the past month the stocks gain 6.29%, bringing three-month performance to 38.07% and six-month performance to 37.11%. The mean recommendation of analysts for this stock is 1.80. (where 1=Buy, 5=Sale).
Vipshop Holdings Limited, through its subsidiaries, operates as an online discount retailer for various brands in the People’s Republic of China. It offers a range of branded products, counting apparel for women, men, and children; fashion goods; cosmetics; home goods and other lifestyle products; footwear; sportswear and sporting goods; luxury goods; and gifts and miscellaneous products. The company provides its branded products through its vipshop.com and vip.com websites, in addition to its cellular phone application. Vipshop Holdings Limited was founded in 2008 and is headquartered in Guangzhou, the People’s Republic of China.
Cerus Corporation (NASDAQ:CERS), enhanced 4.58%, and closed at $4.34.The stock has the beta value of 1.76, and its volatility for the week is 4.02%, while for the month it is 4.76%. The company has the market capitalization of $394.99M. The company holds the book value per share of 0.53, whereas cash per share is 0.57. Price to book ratio remained 8.19, while price to sale ratio is 10.69. Analysts mean recommendation for the stock is said to be 1.50 (where 1=Buy, 5=sale).
Cerus Corporation, together with its partner, Cerus Europe B.V., operates as a biomedical products company in Europe, the Ordinarywealth of Independent States, and the Middle East. The company develops and commercializes the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company’s INTERCEPT Blood System for platelets is designed to inactivate blood-borne pathogens in platelets donated for transfusion; INTERCEPT Blood System for plasma is designed to inactivate blood-borne pathogens in plasma donated for transfusion; and INTERCEPT Blood System for red blood cells is designed to inactivate blood-borne pathogens in red blood cells donated for transfusion.
Castlight Health Inc (NYSE:CSLT), rose 4.57%, and closed at $9.38. The company has the market capitalization of $824.18M. On the other hand the stock’s volatility for the week is 6.90%, and for the month is 6.40%. The stock’s price to book ratio is 4.81, however price to sale ratio is 4.48. Analyst’s mean recommendation regarding this stock is 2.30. (where 1=Buy, 5=Sale).
Castlight Health, Inc. provides cloud-based software in the United States. Its software enables enterprises to understand and manage health care spending. It offers Enterprise Healthcare Cloud that transforms external and internal complex data into transparent and useful information. The company also provides communication and engagement, implementation, customer support, and training services. It serves self-insured employers in a range of industries, such as education, manufacturing, retail, technology, and government. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was founded in 2008 and is headquartered in San Francisco, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
